Frankfurt - Delayed Quote EUR

Synektik Spólka Akcyjna (A2P.F)

50.40
-3.25
(-6.06%)
As of 9:15:02 AM GMT+2. Market Open.
Currency in PLN All numbers in thousands
Download
Breakdown
TTM
9/30/2024
9/30/2023
9/30/2022
9/30/2021
Total Revenue
555,953.95
624,121.79
446,871.57
166,860.94
128,627.45
Cost of Revenue
368,297.98
434,236.60
315,048.89
118,355.48
98,362.17
Gross Profit
187,655.97
189,885.19
131,822.67
48,505.46
30,265.28
Operating Expense
83,147.18
81,268.09
61,172.61
37,081
18,914.16
Operating Income
104,508.78
108,617.10
70,650.07
11,424.46
11,351.12
Net Non Operating Interest Income Expense
-135.09
-1,296.57
-1,709.90
-1,362.52
-778.31
Pretax Income
101,283.41
103,908.18
65,674.90
12,288.92
10,221.41
Tax Provision
20,257.81
21,342.26
13,222.71
1,987.72
1,837.60
Net Income Common Stockholders
81,025.60
82,565.91
52,452.19
10,301.21
8,383.81
Diluted NI Available to Com Stockholders
81,025.60
82,565.91
52,452.19
10,301.21
8,383.81
Basic EPS
9.50
9.68
6.15
1.21
0.98
Diluted EPS
9.50
9.68
6.15
1.21
0.98
Basic Average Shares
8,529.13
8,529.13
8,529.13
8,529.13
8,529.13
Diluted Average Shares
8,529.13
8,529.13
8,529.13
8,529.13
8,529.13
Total Operating Income as Reported
103,031.97
106,942.73
67,862.32
17,617.90
11,187.18
Total Expenses
451,445.17
515,504.69
376,221.50
155,436.48
117,276.33
Net Income from Continuing & Discontinued Operation
81,025.60
82,565.91
52,452.19
10,301.21
8,383.81
Normalized Income
82,212.69
83,745.01
54,470.88
4,679.67
8,263.87
Interest Income
-824.39
146
193.29
150.10
123.12
Interest Expense
-689.30
1,442.57
1,903.19
1,456.21
483.93
Net Interest Income
-135.09
-1,296.57
-1,709.90
-1,362.52
-778.31
EBIT
100,594.11
105,350.75
67,578.09
13,745.13
10,705.34
EBITDA
118,171.10
121,883.81
82,356.16
25,784.60
18,680.18
Reconciled Cost of Revenue
368,297.98
434,236.60
315,048.89
118,355.48
98,362.17
Reconciled Depreciation
17,577
16,533.07
14,778.07
12,039.47
7,974.84
Net Income from Continuing Operation Net Minority Interest
81,025.60
82,565.91
52,452.19
10,301.21
8,383.81
Total Unusual Items Excluding Goodwill
-1,483.88
-1,483.88
-2,527.58
6,706.27
146.23
Total Unusual Items
-1,483.88
-1,483.88
-2,527.58
6,706.27
146.23
Normalized EBITDA
119,654.98
123,367.69
84,883.74
19,078.33
18,533.95
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
-296.79
-304.78
-508.89
1,084.73
26.29
9/30/2021 - 3/6/2024

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

8ZF.F Polarean Imaging plc
0.0005
0.00%
 
PHIA.F Koninklijke Philips N.V.
21.40
0.00%
 
3XV.F Xvivo Perfusion AB (publ)
28.78
+4.05%
 
NEOLA.ST Neola Medical AB (publ)
2.4400
0.00%
 
LT3.F Axogen, Inc.
10.10
-11.40%
 
PHIAa.XC
 
EPIS-B.ST Episurf Medical AB (publ)
0.1180
+6.31%
 
CGHC Capital Group Holdings, Inc.
0.0002
0.00%
 
VIRO.CO ViroGates A/S
6.66
0.00%
 
MHC.L MyHealthChecked PLC
13.50
0.00%